TuHURA BIOSCIENCES, INC./NV Net Cash Provided by (Used in) Investing Activities, Continuing Operations
TuHURA BIOSCIENCES, INC./NV (HURA) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$20.96 thousand for the 12-month period ending 2017-06-30, per its 10-K filed 2017-09-27.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-09-27
- TuHURA BIOSCIENCES, INC./NV net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$20.96K.
- TuHURA BIOSCIENCES, INC./NV net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$16.76K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|
| 2017-06-30 | -$20.96K 10-K · filed 2017-09-27 |
| 2016-06-30 | -$16.76K 10-K · filed 2017-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |